Personal information

Other IDs

SciProfiles: 2024018

Countries

China

Activities

Collapse all

Employment (8)

Peking University Cancer Hospital: Beijing, CN

2011 to present | Vice President
Employment
Source: Self-asserted source
Xiangqian Su

Peking University Cancer Hospital: Beijing, CN

2009 to present | Professor，Director (Department of Gastrointestinal Surgery IV/Minimally Invasive Gastrointestinal Surgery)
Employment
Source: Self-asserted source
Xiangqian Su

Peking University Cancer Hospital: Beijing, CN

2008 to 2009 | Professor (Department of Surgery)
Employment
Source: Self-asserted source
Xiangqian Su

University of California: CA, CA, US

2007 to 2008 | Research associate
Employment
Source: Self-asserted source
Xiangqian Su

Peking University Cancer Hospital: Beijing, CN

2000 to 2007 | Associate professor (Department of Surgery)
Employment
Source: Self-asserted source
Xiangqian Su

Peking University Cancer Hospital: Beijing, CN

1996 to 2000 | Attending surgeon (Department of Surgery)
Employment
Source: Self-asserted source
Xiangqian Su

The Affiliated Hospital of Inner Mongolia Medical University: Hohhot, Inner Mongolia, CN

1991 to 1996 | Attending surgeon (Department of Surgery)
Employment
Source: Self-asserted source
Xiangqian Su

The Affiliated Hospital of Inner Mongolia Medical University: Hohhot, Inner Mongolia, CN

1984 to 1991 | Surgical resident (Department of Surgery)
Employment
Source: Self-asserted source
Xiangqian Su

Education and qualifications (2)

Peking University: Beijing, CN

1996 to 1999 | Master Degree of Medicine
Education
Source: Self-asserted source
Xiangqian Su

Inner Mongolia Medical University: Hohhot, CN

1979 to 1984 | Bachelor Degree of Medicine
Education
Source: Self-asserted source
Xiangqian Su

Professional activities (5)

Society of American Gastrointestinal and Endoscopic Surgeons: CA, CA, US

Membership
Source: Self-asserted source
Xiangqian Su

European Association for Endoscopic Surgery: Eindhoven, NL

Membership
Source: Self-asserted source
Xiangqian Su

Chinese Medical Association: Beijing, CN

Membership
Source: Self-asserted source
Xiangqian Su

Chinese Anti-Cancer Association: Tianjin, CN

Membership
Source: Self-asserted source
Xiangqian Su

American College of Surgeons: Chicago, IL, US

Membership
Source: Self-asserted source
Xiangqian Su

Funding (4)

GXYLT1 and its mutant induced the crosstalk between Notch and mTOR signaling pathway which regulated Warburg effect and metastasis in colorectal cancer

2019-01 to 2022-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
GRANT_NUMBER:

81872022
Source: Self-asserted source
Xiangqian Su

Safety and efficacy of No.10 lymph node dissection with presevation of spleen in laparoscopic D2 radical gastrectomy for advanced gastric cancer

2018-01 to 2020-12 | Grant
Capital’s Funds for Health Improvement and Research (Beijing, CN)
GRANT_NUMBER:

CFH 2018-2-2153
Source: Self-asserted source
Xiangqian Su

The mechanism of ENST00000428100 regulating mTOR signaling pathway by MACC1 and determing the metabolic plasticity of colorectal cancer

2017-01 to 2020-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
GRANT_NUMBER:

81672439
Source: Self-asserted source
Xiangqian Su

The mechanism of SOK1 regulating Warburg effects by mTOR signaling pathway in colorectal cancer

2016-01 to 2018-12 | Grant
Beijing Municipal Natural Science Foundation (Beijing, CN)
GRANT_NUMBER:

7162039
Source: Self-asserted source
Xiangqian Su

Works (7)

Neutrophil-to-Lymphocyte Ratio as an Early Predictor of Symptomatic Anastomotic Leakage in Patients after Rectal Cancer Surgery: A Propensity Score-Matched Analysis

Journal of Personalized Medicine
2022-12 | Journal article | Author
DOI: 10.3390/jpm13010093
Contributors: Fei Tan; Kai Xu; QI XINYU; Pin Gao; Maoxing Liu; Zhendan Yao; Nan Zhang; Hong Yang; Chenghai Zhang; Jiadi Xing et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.

The Lancet. Oncology
2021-02-12 | Journal article
DOI: 10.1016/s1470-2045(20)30685-9
PMID: 33587893
Source: Self-asserted source
Xiangqian Su

Phenotype molding of T cells in colorectal cancer by single-cell analysis.

International journal of cancer
2020-01-21 | Journal article
DOI: 10.1002/ijc.32856
PMID: 31901134
Source: Self-asserted source
Xiangqian Su

KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.

International journal of oncology
2018-08-29 | Journal article
DOI: 10.3892/ijo.2018.4546
PMID: 30226594
PMC: PMC6192758
Source: Self-asserted source
Xiangqian Su

STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.

Journal of experimental & clinical cancer research : CR
2018-07-11 | Journal article
DOI: 10.1186/s13046-018-0808-1
PMID: 29996891
PMC: PMC6042396
Source: Self-asserted source
Xiangqian Su

Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.

International journal of cancer
2017-11-27 | Journal article
DOI: 10.1002/ijc.31140
PMID: 29105743
Source: Self-asserted source
Xiangqian Su

Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2016-02-22 | Journal article
DOI: 10.1200/jco.2015.63.7215
PMID: 26903580
Source: Self-asserted source
Xiangqian Su
How many people are using ORCID?